Thursday, September 3, 2026
spot_img

Correction: Director/PDMR Shareholding

Correction to announcement made at 10:52 on 30 April 2025: Correction to shares issued to PDMR’s

Albion Crown VCT PLC (the “Company”)
Director/PDMR Transaction

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1 Details of the person discharging managerial / persons closely associated
           
a) Name   Ian Spence – Director of Albion Crown VCT PLC    
           
2 Reason for notification        
           
a) Position/status   PDMR/Director    
           
b) Initial notification/Amendment Initial notification    
           
3) Details of the issuer, emission allowance market participation, auction platform,
  auctioneer or auction monitor    
           
a) Name   Albion Crown VCT PLC  
           
b) LEI   213800SYIQPA3L3T1Q68  
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
  (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
           
a) Description of the financial instrument, type of instrument   ordinary shares of nominal value 1 penny each    
           
  Identification code   GB0002577434    
           
b) Nature of the transaction   Issue of shares under the Dividend Reinvestment Scheme
           
c) Price(s) and volume(s)   Price Volume Amount
      £0.3039 1031 £313.32
d) Aggregated information        
           
  – Aggregated volume       £313.32

           
e) Date of the transaction   30 April 2025    
           
f) Place of the transaction   London Stock Exchange  

1 Details of the person discharging managerial / persons closely associated
           
a) Name   Pamela Garside – Director of Albion Crown VCT PLC    
           
2 Reason for notification        
           
a) Position/status   PDMR/Director    
           
b) Initial notification/Amendment Initial notification    
           
3) Details of the issuer, emission allowance market participation, auction platform,
  auctioneer or auction monitor    
           
a) Name   Albion Crown VCT PLC  
           
b) LEI   213800SYIQPA3L3T1Q68  
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
  (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
           
a) Description of the financial instrument, type of instrument   ordinary shares of nominal value 1 penny each    
           
  Identification code   GB0002577434    
           
b) Nature of the transaction   Scheme Issue of shares under the Dividend Reinvestment
           
c) Price(s) and volume(s)   Price Volume Amount
      £0.3039 2861 £869.46
d) Aggregated information        
           
  – Aggregated volume       £869.46
           
e) Date of the transaction   30 April 2025    
           
f) Place of the transaction   London Stock Exchange  

Date of notification

30 September 2025

For further information please contact:

Vikash Hansrani

Operations Partner

Albion Capital Group LLP

Tel: 020 7601 1850

Powered by SlickText.com

Hot this week

eSIM Plans Launch on the BOSS Revolution App, Offering High-Speed Connectivity in 190+ Countries

BOSS Revolution app customers get a 20% discount on...

Landsbankinn hf.: Moody’s assigns initial rating to Landsbankinn

Moody’s Ratings has today assigned Landsbankinn an issuer and...

Canadian General Investments: Investment Update – Unaudited

TORONTO, Canada, Sept. 03, 2026 (GLOBE NEWSWIRE) --...

Transparency Declaration Notification

Regulated information In accordance with the requirements of...

Topics

Landsbankinn hf.: Moody’s assigns initial rating to Landsbankinn

Moody’s Ratings has today assigned Landsbankinn an issuer and...

Canadian General Investments: Investment Update – Unaudited

TORONTO, Canada, Sept. 03, 2026 (GLOBE NEWSWIRE) --...

Transparency Declaration Notification

Regulated information In accordance with the requirements of...

GENFIT to Host Virtual KOL Event Focused on MASH Diagnostics on September 9, 2026  

Presentations will highlight the clinical utility and long-term commercial...
spot_img

Related Articles

Popular Categories

spot_img